MacroGenics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 10.4 million compared to USD 41.73 million a year ago. Net income was USD 17.55 million compared to net loss of USD 24.81 million a year ago. Basic earnings per share from continuing operations was USD 0.28 compared to basic loss per share from continuing operations of USD 0.4 a year ago. Diluted earnings per share from continuing operations was USD 0.28 compared to diluted loss per share from continuing operations of USD 0.4 a year ago.
For the nine months, revenue was USD 48.03 million compared to USD 78.84 million a year ago. Net income was USD 37.01 million compared to net loss of USD 132.56 million a year ago. Basic earnings per share from continuing operations was USD 0.6 compared to basic loss per share from continuing operations of USD 2.16 a year ago. Diluted earnings per share from continuing operations was USD 0.6 compared to diluted loss per share from continuing operations of USD 2.16 a year ago.